The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Transition to ISO 15189 : 2012 for Cytopathology Laboratories Part 1: General and Management Requirements
|
|
Author(s): Eleftherios Vavoulidis (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece), Stavros Archondakis (401 General Military Hospital of Athens, Athens, Greece), Maria Nasioutziki (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece), Ourania Oustambasidou (401 General Military Hospital of Athens, Athens, Greece), Angelos Daniilidis (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece), Konstantinos Dinas (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece)and Aristotelis Loufopoulos (Medical School, Aristotle University of Thessaloniki and Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece)
Copyright: 2016
Volume: 5
Issue: 3
Pages: 21
Source title:
International Journal of Reliable and Quality E-Healthcare (IJRQEH)
Editor(s)-in-Chief: Anastasius Moumtzoglou (Hellenic Society for Quality & Safety in Healthcare and P. & A. Kyriakou Children's Hospital, Greece)
DOI: 10.4018/IJRQEH.2016070101
Purchase
|
Abstract
Nowadays, due to the latest advances in Laboratory Medicine, diagnostic medical laboratories with their highly qualified personnel and state-of-the-art analytical equipment, have completely changed the way modern healthcare is offered. In order to maintain or even increase the already high quality level of the provided testing services, diagnostic laboratories including the cytopathology ones, need to design and apply a Quality Management System (QMS) in agreement with the requirements of the ISO 15189 International Standard. The authors present their experience on the implementation of such a QMS in cytopathology laboratories and highlight the most important general and management parameters that should be taken into consideration when moving from ISO 15189:2007 to the latest ISO 15189:2012. In addition, useful recommendations and suggestions that could make the transition to the latest Standard easier are included. Finally, possible issues and potential adverse events associated with the laboratory's implementation of the ISO 15189:2012 are also described.
Related Content
|
Marlon Luca Machal.
© 2024.
16 pages.
|
|
Dantong Li, Guixin Li, Shuang Li, Ashley Bang.
© 2024.
12 pages.
|
|
David Opeoluwa Oyewola, Emmanuel Gbenga Dada, Sanjay Misra.
© 2024.
21 pages.
|
|
Bin Hu, Gregory T. MacLennan.
© 2024.
11 pages.
|
|
Neetu Singh, Upkar Varshney.
© 2024.
17 pages.
|
|
Long Liu, Zhankui Zhai, Weihua Zhu.
© 2024.
10 pages.
|
|
Lucy M. Lu, Richard S. Segall.
© 2024.
18 pages.
|
|
|